

Genetic Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The genetic testing market is experiencing robust growth, currently valued at approximately $21 billion and projected to reach over $35 billion by 2028. Key factors driving this expansion include rising healthcare awareness, technological advancements, and increasing demand for personalized medicine, indicating a significant shift towards consumer-driven healthcare solutions. Request Sample Report
◍ Abbott
◍ bioMérieux
◍ Bio-Rad Laboratories
◍ F. Hoffmann-La Roche
◍ Myriad Genetics
◍ QIAGEN
◍ Quest Diagnostics
The genetic testing market features key players like Abbott, bioMérieux, Bio-Rad, Roche, Myriad Genetics, QIAGEN, and Quest Diagnostics. These companies enhance market growth through innovative testing solutions and extensive R&D, contributing to improved diagnostics and personalized medicine. Notable revenue figures include:
- Abbott: ~$43 billion
- Roche: ~$63 billion
- QIAGEN: ~$2 billion
Request Sample Report
◍ Predictive and Diagnostic Testing
◍ Prenatal, Newborn, and Pre-Implantation Testing
◍ Pharmacogenomic Testing
◍ Forensic, Relationship, and Ancestry Testing
Analyzers
Consumables
Request Sample Report
Request Sample Report
$ 1.60 Billion